Name: Tunneling Nanotubes and Intracellular Protrusions Workshop
Start: 2023-10-04T10:00:00-04:00
End: 2023-10-04T14:00:00-04:00

Medical Countermeasures

Biodefense Headlines – 19 September 2023

News Scan September 19, 2023

News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

Smallpox Vaccines: Bavarian Nordic Awarded Another Contract to Supply EU Strategic Reserve

Medical Countermeasures

HHS Extends Partnership with Regeneron to Develop Life-Saving Monoclonal Antibodies

Kyasanur Forest Disease: Promising Experimental Vaccine for Rare Tick-borne Flavivirus

Humanetics to Develop First FDA Approved Drug to Prevent Radiation Injury

New Study Shows Effectiveness of Mpox Vaccine

Disease X: CEPI and University of Oxford Collaborate on Rapid Response Vaccine Technology

Chikungunya Vaccine: Health Canada Moves Forward with Valneva Review

CSL Seqirus Awarded Contract for Influenza A(H5N8) Candidate Vaccine

Allucent Awarded BARDA Contract to Accelerate Next-Generation COVID-19 Booster Vaccines

NIAID Study Shows Low-Dose Marburg Vaccine Effective in Macaques

Imunon Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus

Regeneron Awarded $325M for Development of Next-Gen COVID-19 Monoclonal Antibody Therapy

Project NextGen: HHS Awards $1.4B for COVID Countermeasure Development

Anthrax Vaccine Funding Urged Amid West Africa Outbreak

RedHill Biopharma Highlights Federal Medical Countermeasure Investments

Molnupiravir Blocks SARS-CoV-2 Transmission in Animal Study

Treatments for Poxviruses May Already Exist in Licensed Drugs

U.S. Invests in mAb Treatment for Ebola with New Award to Emergent BioSolutions

After Missing the Mark in COVID Trial, Revive Therapeutics Pursues Bucillamine as CBRN Medical Countermeasure

Smallpox Countermeasures: U.S. Awards $138M to Siga Technologies for TPOXX

Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine

Biodefense Headlines – 19 September 2023

The Long Journey to Eliminate the Deadly U.S. Chemical Weapons Stockpile

OneLab Summit 2023

Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

Tunneling Nanotubes and Intracellular Protrusions Workshop